What is the recommended use and dosage of Levophed (norepinephrine) in treating hypotension due to septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Use and Dosage of Levophed (Norepinephrine) in Septic Shock

Norepinephrine is the first-choice vasopressor for managing septic shock, with a recommended initial dosage of 0.05-0.1 μg/kg/min, titrated by 0.05-0.1 μg/kg/min every 5-15 minutes to achieve a target mean arterial pressure (MAP) ≥65 mmHg. 1

Dosing Protocol for Norepinephrine in Septic Shock

  • Initial dose: 0.05-0.1 μg/kg/min
  • Titration: Increase by 0.05-0.1 μg/kg/min every 5-15 minutes
  • Target: Mean arterial pressure (MAP) ≥65 mmHg
  • Maximum dose: No absolute maximum defined, but doses above 1 μg/kg/min are associated with mortality rates over 80% 2

Administration Considerations

  • Arterial line monitoring should be established when using vasopressors 1
  • While central venous administration is preferred, peripheral administration may be considered in emergent situations when central access is not immediately available 3
  • Early administration of norepinephrine is beneficial as it:
    • Rapidly corrects profound hypotension (which independently increases mortality)
    • Increases cardiac output
    • Improves microcirculation
    • Helps avoid fluid overload 4, 5

Monitoring Parameters During Treatment

  • Blood pressure (target MAP ≥65 mmHg)
  • Heart rate
  • Urine output (target ≥0.5 ml/kg/h)
  • Skin perfusion
  • Mental status
  • Lactate clearance
  • Renal and liver function tests
  • SpO₂ (target ≥95%) 1

When to Consider Second-Line Agents

If hypotension persists despite escalating norepinephrine doses:

  1. Add vasopressin (maximum dose 0.03 U/min) to raise MAP or decrease norepinephrine requirements 1, 2
  2. Consider epinephrine if there's evidence of myocardial depression 1, 6
  3. Consider dobutamine (2.5-20 μg/kg/min) for myocardial dysfunction or persistent hypoperfusion despite adequate blood pressure 1

Special Considerations

  • For patients with chronic hypertension, consider a higher MAP target 5
  • Early norepinephrine administration should be prioritized in patients with:
    • Profound hypotension (diastolic BP ≤40 mmHg)
    • High diastolic shock index (heart rate/diastolic blood pressure ≥3)
    • Risk of fluid accumulation
    • Conditions where fluid overload would be particularly harmful (ARDS, intra-abdominal hypertension) 4
  • Consider hydrocortisone (up to 300 mg/day) if escalating vasopressor doses are required 1

Common Pitfalls to Avoid

  • Delayed vasopressor initiation: Don't wait for complete fluid resuscitation before starting norepinephrine in profound shock 4, 5
  • Inadequate monitoring: Always establish arterial line monitoring when using vasopressors 1
  • Using dopamine: Dopamine is no longer recommended in septic shock due to higher rates of cardiac arrhythmias without mortality benefit 6
  • Excessive fluid administration: Early norepinephrine can reduce the volume of fluids required and prevent complications of fluid overload 4
  • Failure to recognize refractory shock: Consider adding second-line agents before norepinephrine exceeds 1 μg/kg/min 2

References

Guideline

Vasopressor Management in Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vasopressors to treat refractory septic shock.

Minerva anestesiologica, 2020

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.